Paper42818878PubMed
The key mechanisms and intervention strategies of cell-type-specific mitochondrial metabolism in ophthalmic diseases.
Zhang S and 4 others. Front Cell Dev Biol, 2026.
Cite this record
ConductScience Library. The key mechanisms and intervention strategies of cell-type-specific mitochondrial metabolism in ophthalmic diseases. Papers, record 42818878. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42818878
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The key mechanisms and intervention strategies of cell-type-specific mitochondrial metabolism in ophthalmic diseases.
- Journal
- Front Cell Dev Biol
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-02
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References96
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41448387 | Mitochondria in corneal physiology and pathology: A mechanistic perspective. | Prog Retin Eye Res | 2026 | https://conductscience.org/library/papers/41448387 | PubMed |
| 2 | 38797339 | Disrupted mitochondrial transcription factor A expression promotes mitochondrial dysfunction and enhances ocular surface inflammation by activating the absent in melanoma 2 inflammasome. | Free Radic Biol Med | 2024 | https://conductscience.org/library/papers/38797339 | PubMed |
| 3 | 38280852 | Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS/STING inflammation during aging. | Nat Commun | 2024 | https://conductscience.org/library/papers/38280852 | PubMed |
| 4 | 38890703 | Urolithin A promotes p62-dependent lysophagy to prevent acute retinal neurodegeneration. | Mol Neurodegener | 2024 | https://conductscience.org/library/papers/38890703 | PubMed |
| 5 | 37454969 | Mitophagy in the retina: Viewing mitochondrial homeostasis through a new lens. | Prog Retin Eye Res | 2023 | https://conductscience.org/library/papers/37454969 | PubMed |
| 6 | 32353323 | Vitamin C- and Valproic Acid-Induced Fetal RPE Stem-like Cells Recover Retinal Degeneration via Regulating SOX2. | Mol Ther | 2020 | https://conductscience.org/library/papers/32353323 | PubMed |
| 7 | 37659619 | Integration of systematic review, lipidomics with experiment verification reveals abnormal sphingolipids facilitate diabetic retinopathy by inducing oxidative stress on RMECs. | Biochim Biophys Acta Mol Cell Biol Lipids | 2023 | https://conductscience.org/library/papers/37659619 | PubMed |
| 8 | 38232735 | Augmentation of scleral glycolysis promotes myopia through histone lactylation. | Cell Metab | 2024 | https://conductscience.org/library/papers/38232735 | PubMed |
| 9 | 41994054 | The role of circadian rhythms in the pathogenesis of myopia. | Front Physiol | 2026 | https://conductscience.org/library/papers/41994054 | PubMed |
| 10 | 41169617 | N-Acetyltransferase 2 Inhibits Myopia by Maintaining Mitochondrial Metabolism in Scleral Fibroblasts. | Research (Wash D C) | 2025 | https://conductscience.org/library/papers/41169617 | PubMed |
| 11 | 38897410 | NAD+ supplementation improves mitochondrial functions and normalizes glaucomatous trabecular meshwork features. | Exp Cell Res | 2024 | https://conductscience.org/library/papers/38897410 | PubMed |
| 12 | 28901286 | Biochemical adaptations of the retina and retinal pigment epithelium support a metabolic ecosystem in the vertebrate eye. | Elife | 2017 | https://conductscience.org/library/papers/28901286 | PubMed |
| 13 | 30047517 | Mitochondria in smooth muscle cells of viscera. | J Smooth Muscle Res | 2018 | https://conductscience.org/library/papers/30047517 | PubMed |
| 14 | 32641991 | Bioenergetic Crosstalk between Mesenchymal Stem Cells and various Ocular Cells through the intercellular trafficking of Mitochondria. | Theranostics | 2020 | https://conductscience.org/library/papers/32641991 | PubMed |
| 15 | 36435207 | Inhibition of diabetes-induced Drp1 deSUMOylation prevents retinal vascular lesions associated with diabetic retinopathy. | Exp Eye Res | 2023 | https://conductscience.org/library/papers/36435207 | PubMed |
| 16 | 32756920 | Effects of Diabetes on Mitochondrial Morphology and Its Implications in Diabetic Retinopathy. | Invest Ophthalmol Vis Sci | 2020 | https://conductscience.org/library/papers/32756920 | PubMed |
| 17 | 31136758 | Tanshinone IIa protects retinal endothelial cells against mitochondrial fission induced by methylglyoxal through glyoxalase 1. | Eur J Pharmacol | 2019 | https://conductscience.org/library/papers/31136758 | PubMed |
| 18 | 40930272 | Imbalanced mitochondrial homeostasis in ocular diseases: unique pathogenesis and targeted therapy. | Exp Eye Res | 2025 | https://conductscience.org/library/papers/40930272 | PubMed |
| 19 | 30408422 | Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies. | Expert Opin Biol Ther | 2018 | https://conductscience.org/library/papers/30408422 | PubMed |
| 20 | 41579974 | Chronic stress-induced steroids mediate mitochondrial fission and fibrosis in the trabecular meshwork via the MIEF1-MAOA complex. | Free Radic Biol Med | 2026 | https://conductscience.org/library/papers/41579974 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42818878
GET https://conductscience.org/api/papers/v1/42818878/references?page=2